Agile Capital Markets has served as the exclusive financial advisor to Cilcare on its exclusive option agreement for innovative hearing disorder treatments with Shionogi & Co., Ltd. Under the terms of the agreement: - Cilcare will receive an upfront payment of €15 million - Cilcare is eligible to receive up to €400 million in milestone payments upon successful development and commercialization of the drug candidates Congratulations to Celia Belline, Jérome Geoffroy and the rest of the Cilcare team! More information on https://lnkd.in/eDXzz4wi #biotech #hearingdisorder #ai #synaptopathy #frenchtech #fundraising #investmentbanking
Agile Capital Markets
Banques d’investissement
Paris, Île-de-France 946 abonnés
Agile Capital Markets is a specialized investment bank for innovative healthcare.
À propos
Agile Capital Markets is a specialized investment bank for innovative healthcare. Agile Capital Markets in a nutshell: - €1.05Bn+ secured, size of transactions from €10M to €150M+ - 1,000+ investors can be reached, WW spread - 90% of transactions with international syndications - For both Private & Public Equity - 90% of clients performed their next deal with us - Exclusively for Biotech, Medtech, Digital Health & Healthcare Services companies Our services include, but are not limited to: Capital raising of series A to C+, Merger & Acquisitions (buy side, sell side), Initial Public Offerings advisory, secondary offering, strategic advice, licensing deal negotiation, business model and business planning. We know how hard it is to bring innovation in healthcare, we recognize the hard-lifting work that is required to win. We, at Agile Capital Markets, are bringing our help and international network to secure the financial means for you to do just that.
- Site web
-
https://agilecapitalmarkets.com/
Lien externe pour Agile Capital Markets
- Secteur
- Banques d’investissement
- Taille de l’entreprise
- 2-10 employés
- Siège social
- Paris, Île-de-France
- Type
- Partenariat
- Fondée en
- 2016
Lieux
-
Principal
Obtenir l’itinéraire
33, Rue La Fayette
75009 Paris, Île-de-France, FR
Employés chez Agile Capital Markets
Nouvelles
-
Agile Capital Markets has served as the exclusive financial advisor to BIOPHTA, France-based pre-clinical stage company, developing a new standard or care for several eye diseases. Congratulations to Jean GARREC, Jean Cuiné and the rest of the Biophta team! More information on: https://lnkd.in/eDUdhgDX #biotech #ophthalmology #frenchtech #fundraising #investmentbanking
-
-
📢 Agile Capital Markets is thrilled to announce the promotion of Morgane Bonnevay to Vice President Healthcare. 🎉 “Over the last year, Morgane has been instrumental in several international transactions including buy side M&A mandates, fundraising and licensing deals. We are very happy to announce Morgane as Vice President.” Eric Cohen and Sophie Baratte, Partners.
-
-
📢 Agile Capital Markets is hiring its next cohort of interns. Join us! 🙂 - Background in Life Sciences (MD, PharmD, PhD, Engineer) and Corporate Finance (MiM, MSc) – gap year internship welcome. - Early work experience and proficiency in English required - Paris based - Competitive salary and bonus hr@agilecapitalmarkets.com #investmentbanking #fundraising #mergersacquisitions #biotech #medtech #digitalhealth
-
-
Our Managing Director Eric COHEN will be live today at 6:30pm CET in 100% HealthTech, the live of France Biotech, to discuss the launch of "Invest in HealthTech" executive program for institutional investors (Limited Partners); and alongside Philippe Tibi, Rodolphe BESSERVE, Managing Partner, ARBEVEL & Lise ALTER, Director of the Health Innovation Agency. Executive program organized by France Biotech, the Agence de l'innovation en santé, Direction générale du Trésor and operated by École Polytechnique. Under the patronage of French Ministers Aurélien Rousseau, Minister for Health and Prevention, Roland Lescure, Minister Delegate for Industry & Jean-Noël Barrot, Minister Delegate for the Digital Sector.
🔥 J-2 « 100% HealthTech, le live de France Biotech #6 » en partenariat avec BiotechFinances - Medtech - Santé Numérique - DTx - Intelligence Artificielle ! >> Bloquez votre agenda ici : https://lnkd.in/eUhzHa7g >> Connectez-vous sur le 𝘀𝗶𝘁𝗲 𝗶𝗻𝘁𝗲𝗿𝗻𝗲𝘁 𝗱𝗲 𝗙𝗿𝗮𝗻𝗰𝗲 𝗕𝗶𝗼𝘁𝗲𝗰𝗵 https://lnkd.in/eu8PaDgk ou sur 𝗻𝗼𝘁𝗿𝗲 𝗰𝗼𝗺𝗽𝘁𝗲 𝗟𝗶𝗻𝗸𝗲𝗱𝗜𝗻, le 9 novembre 𝗲𝗻 𝗹𝗶𝘃𝗲 𝗮̀ 𝟭𝟴𝗵𝟯𝟬 ! 🔍 Ne manquez pas : 🔢 « Le chiffre du jour : 2 » L’APHM (Assistance Publique - Hopitaux de Marseille) accueille la deuxième édition du « CHU Healthtech Connexion Day ». Présentation des enjeux et grandes orientations de cette 2ème édition avec Francois Cremieux, Directeur de l’AP-HM 🎙️ « Le grand angle » Autour du lancement de la formation « Investir dans la HealthTech » proposée par l’Agence de l'innovation en santé, la Direction générale du Trésor (French Treasury), la mission « Tibi » et France Biotech, opérée par l’École Polytechnique, avec Eric COHEN, Managing Director, Agile Capital Markets, Rodolphe BESSERVE, Managing Partner, ARBEVEL & Lise ALTER, directrice de l’Agence Innovation Santé. Consultez le communiqué de presse ici : https://lnkd.in/eNr3WhPZ 🗣️ « Parole d’entrepreneurs » L’accélérateur Industries et Technologies de Santé, 2ème promotion avec Estelle Nguyen, Responsable de programmes accélérateur, Bpifrance et Pierre Charrier, CEO et Shareholder, DIVERCHIM 🔍 « Le focus » Sur l’étude sur la soutenabilité du système de soins de France Biotech. Entretien avec Marc LEFRANCOIS, Associé, Cabinet CMI Stratégies 🗣️ « Parole d’entrepreneurs » Stephane Tholander, Conseiller spécial auprès de la Présidence de France Biotech et Alexandre Prihnenko, directeur général d’Oviva reviennent sur le lancement de la Task Force DTX de France Biotech 🔐 « Le décryptage » Des grands défis « numérique en santé mentale » & « dispositifs numériques pour le bien-vieillir » avec Line FARAH, qui en est directrice & Franck Mouthon, président de France Biotech 🔍 « Biotech Insight », en partenariat avec BiotechFinances - Medtech - Santé Numérique - DTx - Intelligence Artificielle Zoom sur les faits marquants de l'actualité des biotechs françaises avec Jacques-Bernard Taste, directeur de la publication Biotech Finances 📰 « L’actu de France Biotech » Olivier Chabanon, directeur général France Biotech, présentera les grands rdv à venir de l'association. Et d’autres intervenants à venir !
-
-
Agile Capital Markets a republié ceci
We are thrilled to announce that Agile Capital Markets is joining us as a sponsor of HealthTech For Care this year! Don't miss the chance to connect with the Agile Capital Markets team during the upcoming HealthTech Innovation Days in Paris on October 24th and 25th! For additional details, visit: https://htfc-eu.com/htid/ #InnovationInHealthTech #DigitalHealthSolutions #MedTechAdvances #PatientCareFirst #FutureOfMedicine #SanofiSupportsHTFC #HealthcareInnovation #HealthTechforcare #HealthTechinnovationdays #HealthTechforpatients
-
-
🚀 Last week, our Partner Sophie Baratte, MBA, PhD had the honor to be part of fascinating panel entitled "How to Fund MedTech?" organized by Brabantse Ontwikkelings Maatschappij (BOM), in the Netherlands. 🌟 Alongside distinguished industry professionals, including Janke Dittmer, General Partner at Gilde Healthcare; Eliane Schutte, CEO of Xeltis; Hubert Martens, CEO of Salvia BioElectronics, with Floris Hamel, Investment Manager Life Sciences & MedTech at BOM, as a moderator, we delved into the intricate landscape of funding strategies in the MedTech sector. A big thank you to the organizers for bringing together this panel, and to everyone who attended and engaged in the conversation. If you're interested in learning more about the key takeaways or if you have any questions about MedTech funding, feel free to reach out. #MedTech #FundingStrategies #Innovation #InvestmentBanking
-
-
Agile Capital Markets is looking for interns! - Background in Life Sciences (MD, PharmD, PhD, Engineer) and Corporate Finance (MiM, MSc) – gap year internshipwelcome. - Early work experience and proficiency in English required - Paris based - Competitive salary and bonus hr@agilecapitalmarkets.com #investmentbanking #fundraising #mergersacquisitions #biotech #medtech #digitalhealth
-